AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric ...
Identified as “Mr. A,” the man experienced “suffering and functional decline” following three vaccinations for SARS-CoV-2. He also suffered from depression, post-traumatic stress disorder, anxiety and ...